Different Effects of Growth Factors on Proliferation and Matrix Production of Normal and Fibrotic Human Lung Fibroblasts

Overview of attention for article published in Lung, August 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

patent: 9 patents

Citations

dimensions_citation: 157 Dimensions

Readers on

mendeley: 100 Mendeley
citeulike: 2 CiteULike

Summary Patents Dimensions citations

So far, Altmetric has seen 9 patents that reference this research output.

Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

Grant US-10744154-B2

United States of America

Method for treatment of pulmonary fibrosis

Grant US-9339515-B2

United States of America

Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

Grant US-9200090-B2

United States of America

Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

Grant US-8722645-B2

United States of America

Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

Grant US-8367638-B2

United States of America

Galactose—pronged polysaccharides in a formulation for antifibrotic therapies

Grant US-8236780-B2

United States of America

Selectively depolymerized galactomannan polysaccharide

Grant US-7893252-B2

United States of America

GALACTOSE-PRONGED POLYSACCHARIDES IN A FORMULATION FOR ANTIFIBROTIC THERAPIES

Application WO-2008011216-A3

World Intellectual Property Organisation (WIPO)

GALACTOSE-PRONGED POLYSACCHARIDES IN A FORMULATION FOR ANTIFIBROTIC THERAPIES

Application WO-2008011216-A2

World Intellectual Property Organisation (WIPO)